FDA NDC Directory · JSON-LD · Markdown

Cholestyramine

NDC 33342-319 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA209109
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCHOLESTYRAMINE (4 g/5.7g)
Marketing started20241121
Package count3

External sources

Source: openFDA. Public-domain (CC0).